Literature DB >> 18061530

Molecular alterations in the tumor suppressor gene WWOX in oral leukoplakias.

Flávio Juliano Pimenta1, Gabriela Tavares Cordeiro, Luiz Gustavo Garcia Santos Pimenta, Michelle Beatriz Viana, Joyce Lopes, Marcus Vinícius Gomez, C Marcelo Aldaz, Luiz De Marco, Ricardo Santiago Gomez.   

Abstract

Oral leukoplakia is the most prevalent and potentially malignant disorder of the oral mucosa. Previous studies have demonstrated that molecular changes of the WWOX gene (WW-domain containing oxidoreductase), a candidate tumor suppressor gene located at 16q23.3-24.1 that spans FRA16D, the second most common fragile site, are present in several malignant neoplasias, including oral squamous cell carcinoma. In this report, the role of the WWOX gene was investigated in 23 cases of oral leukoplakias. Using nested RT-PCR and immunohistochemistry, altered mRNA transcription and/or reduced Wwox protein expression was observed in 35% of the lesions when compared with normal mucosa. The majority of lesions (4/6) with altered transcripts had a reduction in the expression of Wwox protein. Although normal WWOX expression was found in some lesions with dysplasia, all lesions with WWOX mRNA and/or protein expression showed histological evidence of dysplasia and none of the cases without dysplasia presented this alteration. These results show that the WWOX gene alteration is an early genetic alteration and may contribute to oral carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18061530      PMCID: PMC4143237          DOI: 10.1016/j.oraloncology.2007.08.019

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  41 in total

1.  WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.

Authors:  A K Bednarek; C L Keck-Waggoner; R L Daniel; K J Laflin; P L Bergsagel; K Kiguchi; A J Brenner; C M Aldaz
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

2.  Direct correlation between FRA3B expression and cigarette smoking.

Authors:  Constance K Stein; Thomas W Glover; J Lynn Palmer; Bonnie S Glisson
Journal:  Genes Chromosomes Cancer       Date:  2002-07       Impact factor: 5.006

Review 3.  Common chromosomal fragile sites and cancer: focus on FRA16D.

Authors:  Louise V O'Keefe; Robert I Richards
Journal:  Cancer Lett       Date:  2005-10-20       Impact factor: 8.679

4.  WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.

Authors:  A K Bednarek; K J Laflin; R L Daniel; Q Liao; K A Hawkins; C M Aldaz
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

5.  Low expression of fragile histidine triad gene correlates with high proliferation in head and neck squamous cell carcinoma.

Authors:  H Mineta; Ka Miura; S Takebayashi; Ki Misawa; Y Ueda; I Suzuki; M Ito; J Wennerberg
Journal:  Oral Oncol       Date:  2003-01       Impact factor: 5.337

6.  Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus.

Authors:  M Mori; K Mimori; T Shiraishi; H Alder; H Inoue; Y Tanaka; K Sugimachi; K Huebner; C M Croce
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

7.  WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.

Authors:  Sai Yendamuri; Tamotsu Kuroki; Francesco Trapasso; Adam C Henry; Kristoffel R Dumon; Kay Huebner; Noel N Williams; Larry R Kaiser; Carlo M Croce
Journal:  Cancer Res       Date:  2003-02-15       Impact factor: 12.701

Review 8.  Oral cancer and precancerous lesions.

Authors:  Brad W Neville; Terry A Day
Journal:  CA Cancer J Clin       Date:  2002 Jul-Aug       Impact factor: 508.702

9.  Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma.

Authors:  Tamotsu Kuroki; Francesco Trapasso; Takeshi Shiraishi; Hansjuerg Alder; Koshi Mimori; Masaki Mori; Carlo M Croce
Journal:  Cancer Res       Date:  2002-04-15       Impact factor: 12.701

Review 10.  Genetic alterations in cancer as a result of breakage at fragile sites.

Authors:  Nicholas C Popescu
Journal:  Cancer Lett       Date:  2003-03-20       Impact factor: 8.679

View more
  7 in total

Review 1.  WWOX gene and gene product: tumor suppression through specific protein interactions.

Authors:  Zaidoun Salah; Rami Aqeilan; Kay Huebner
Journal:  Future Oncol       Date:  2010-02       Impact factor: 3.404

2.  Exploring the mechanism of WWOX growth inhibitory effects on oral squamous cell carcinoma.

Authors:  Wei Yang; Xiao-Ming Wang; Hong-Yan Yuan; Zhi-Hui Liu; Shuang Gao; Liang Peng
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

3.  The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.

Authors:  Ileana Aderca; Catherine D Moser; Manivannan Veerasamy; Ahmad H Bani-Hani; Ruben Bonilla-Guerrero; Kadra Ahmed; Abdirashid Shire; Sophie C Cazanave; Damian P Montoya; Teresa A Mettler; Lawrence J Burgart; David M Nagorney; Stephen N Thibodeau; Julie M Cunningham; Jin-Ping Lai; Lewis R Roberts
Journal:  J Hepatol       Date:  2008-06-09       Impact factor: 25.083

4.  Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.

Authors:  Xiaohong Li; Patricia C Galipeau; Carissa A Sanchez; Patricia L Blount; Carlo C Maley; Jessica Arnaudo; Daniel A Peiffer; Dmitry Pokholok; Kevin L Gunderson; Brian J Reid
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

5.  Human MutL homolog 1 immunoexpression in oral leukoplakia and oral squamous cell carcinoma: A prospective study in Indian population.

Authors:  Narendra T Chaudhari; Jagdish V Tupkari; Tabita Joy; Manisha S Ahire
Journal:  J Oral Maxillofac Pathol       Date:  2016 Sep-Dec

6.  TMEM207 hinders the tumour suppressor function of WWOX in oral squamous cell carcinoma.

Authors:  Katsuaki Bunai; Hiroshi Okubo; Kimika Hano; Keisuke Inoue; Yusuke Kito; Chiemi Saigo; Toshiyuki Shibata; Tamotsu Takeuchi
Journal:  J Cell Mol Med       Date:  2017-11-22       Impact factor: 5.310

7.  Functional genetic variant in the Kozak sequence of WW domain-containing oxidoreductase (WWOX) gene is associated with oral cancer risk.

Authors:  Hsin-Lin Cheng; Yu-Fan Liu; Chun-Wen Su; Shih-Chi Su; Mu-Kuan Chen; Shun-Fa Yang; Chiao-Wen Lin
Journal:  Oncotarget       Date:  2016-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.